Who Owns Decoy Therapeutics Stock?
NASDAQ: DCOYHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
After hours: 1.50 +1.97%
Ownership breakdown
- Held by institutions
- 9.67%
- Held by insiders
- 10.44%
- Institutional holders
- 6
- Institutions 9.7%
- Insiders 10.4%
- Public and other 79.9%
Who owns Decoy Therapeutics stock?
Institutional investors own about 9.7% of Decoy Therapeutics's shares, spread across 6 institutions that file 13F reports. That level of institutional ownership is relatively low, leaving more of the stock with retail investors and insiders. Insiders, including executives, directors and large founding shareholders, hold 10.44% of DCOY.
The largest institutional holders are Vanguard Capital Management LLC (0.62%), Tower Research Capital LLC (TRC) (0.04%) and UBS Group AG (0.00%). In their latest filings, 2 of the top 4 institutions increased their DCOY positions and 2 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of DCOY
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Vanguard Capital Management LLC | 4.03K | 0.62% | +100.0% |
| Tower Research Capital LLC (TRC) | 256 | 0.04% | -74.9% |
| UBS Group AG | 25 | 0.00% | -95.4% |
| Caitong International Asset Management Co., Ltd | 2 | 0.00% | +100.0% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of DCOY
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 4.03K | 0.62% |
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | 2.90K | 0.44% |
| Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund | 477 | 0.07% |
| Listed Funds Trust-Horizon Kinetics Medical ETF | 21 | 0.00% |
Frequently asked questions
Who is the largest shareholder of Decoy Therapeutics?
Vanguard Capital Management LLC is the largest institutional shareholder of DCOY, owning 0.62% of shares outstanding (4.03K shares) as of its latest 13F filing.
What percentage of Decoy Therapeutics is owned by institutions?
Institutions own about 9.7% of DCOY shares and 10.8% of the public float.
How much of Decoy Therapeutics do insiders own?
Insiders, such as officers and directors, own about 10.44% of DCOY shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.